Research and Development

Showing 15 posts of 9596 posts found.

ICON and Tigermed forge China alliance

April 7, 2010 Research and Development CRO, China, ICON

Contract research organisation ICON is to team up with Tigermed Consulting, a clinical services company based in China. The alliance …
RochePitzer

Frank Pitzer made chief executive at NimbleGen

April 7, 2010 Research and Development NimbleGen, Roche, appointment, research and development

Roche has promoted Dr Frank Pitzer to chief executive for its Madison, US headquartered genomics business NimbleGen. Dr Pitzer has …

Talking Point: Responding to Trial Emergencies

April 6, 2010 Research and Development

Unblinding is only done when it is deemed essential for the patients by the subject’s physician or a regulatory body, …
retacrit

Biosimilars: the great balancing act

April 6, 2010 Research and Development biogenerics, biosimilars

Faced with recessionary pressures, ageing populations, and increasingly expensive therapies, governments are redoubling their efforts to contain healthcare costs. Biologics …
SirJamesBlack

Obituary: Sir James Black

April 6, 2010 Research and Development appointment, research and development

Sir James Black, the British physician and pharmacologist who discovered some of the biggest breakthroughs in medicine in the 20th …
Pfizer payments

Pfizer first to disclose trial payments

April 1, 2010 Research and Development, Sales and Marketing Pfizer, industry reputation, payments

Pfizer has disclosed in full the payments it has made to US doctors to conduct clinical trials and to promote …

New CRO Celerion rises out of MDS divestment

April 1, 2010 Research and Development Celerion, mds

Celerion has completed the acquisition of MDS Pharma Services’ early-stage development and regulatory services business, marking the latter’s exit from …

Chiltern Announces Investment in Endpoint

April 1, 2010 Research and Development

Glenn Kerkhof, Chiltern CEO, stated, “Chiltern’s decision to invest in Endpoint is representative of our commitment to seek collaborations which …

GSK signs RNA therapeutics alliance

March 31, 2010 Research and Development GlaxoSmithKline, Isis, RNA

GlaxoSmithKline has forged a new strategic alliance with Isis Pharmaceuticals to exploit the specialist company’s expertise in anti-RNA therapeutics. California-based …

Boehringer enters the venture capital business

March 31, 2010 Research and Development, Sales and Marketing Boehringer, funding, venture capital

Boehringer Ingelheim is to tap into commercial opportunities in emerging technology by launching its own venture capital business. The Boehringer …

Lilly expands trial supply deal with Thermo

March 31, 2010 Manufacturing and Production, Research and Development Thermo Fisher Scientifitic, lilly

Eli Lilly has expanded a clinical trial materials supply agreement with Thermo Fisher Scientific in yet another deal that sees …

Contract research news in brief

March 30, 2010 Research and Development CRO, Kendle

This week’s round-up of news in the contract research arena includes a fundraising for Irish CRO Venn Life Sciences, ISO …

Antisoma cancer drug fails in phase III

March 29, 2010 Research and Development Antisoma, NSCLC, lung cancer

UK biotech Antisoma has suffered a disappointing late-stage failure with a potential lung cancer treatment it was developing with Novartis. …

Funding boost for UK research

March 29, 2010 Research and Development Cancer Research UK, MRC, UCL, UKCMRI, Wellcome

Prime minister Gordon Brown has pledged £250 million for the planned UK Centre for Medical Research and Innovation (UKCMRI). The …
CLR teamsheet1

Manches promotes Catherine Rohll

March 25, 2010 Business Services, Research and Development Manches, appointment, business services

UK law firm Manches has promoted Catherine Rohll to partner in its life sciences team.A scientist by training with a …
The Gateway to Local Adoption Series

Latest content